Human parvovirus B19 infection in organ transplant recipients

Clinical Transplantation

Volumn 13, Issue 1 I, 1999, Pages 17-24

  Marchand, Sylvie ^a   Tchernia, Gil ^a   Hiesse, Christian ^a   Tertian, Gérard ^a   Cartron, Jeanine ^a   Kriaa, Faiçal ^a   Boubenider, Samir ^a   Goupy, Christophe ^a   Lecointe, Didier ^a   Charpentier, Bernard ^a  

^a BICÊTRE HOSPITAL   (France)

Author keywords

Human parvovirus B19; Intravenous immunoglobulin; Organ transplantation; Pancytopenia

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; VIRUS DNA;

ADULT; ARTICLE; BONE MARROW; CASE REPORT; ERYTHEMA INFECTIOSUM; HUMAN; KIDNEY TRANSPLANTATION; MALE; PANCYTOPENIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECIPIENT;

EID: 0032983928     PISSN: 09020063     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1399-0012.1999.t01-1-130103.x     Document Type: Article

References (63)

1. ANDERSON MJ, JONES SE, FISHER-HOCH SP, LEWIS E, HALL SM, BARTLETT CLR, COHEN BJ, MORTIMER PP, PEREIRA MS. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983: i: 1378.
2. PATTISON JR, JONES SE, HODGSON J, DAVIS LR, WHITE JM, STROUD CE, MURTAZA L. Parvovirus infections and hypoplastic crisis in sickle-cell anemia. Lancet 1981: i: 664.
3. SERJEANT GR, MASON K, TOPLEY JM, SERJEANT BE, PATTISON JR, JONES SE, MOHAMED R. Outbreak of aplastic crisis in sickle-cell anaemia associated with parvovirus-like agent. Lancet 1981: ii: 595.
4. BROWN T, ANAND A, RITCHIE LD, CLEWLEY JP, REID TMS. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984: 2: 1033.
5. COSSART YE, FIELD AM, CANT B, WIDDOWS D. Parvovirus-like particles in human sera. Lancet 1975: 1: 71.
6. KURTZMAN GJ, COHEN BJ, FIELD AM, OSEAS R, BLAESE M, YOUNG NS. Immune response to B19 parvovirus and an antibody defect in persistent viral infection. J Clin Invest 1989: 84: 1114.
7. KURTZMAN GJ, OZAWA K, COHEN B, HANSON G, OSEAS R, YOUNG NS. Chronic bone marrow failure due to persistent B19 parvovirus infection. New Engl J Med 1989: 317: 287.
8. FRICKHOFEN N, CHEN ZJ, YOUNG NS, COHEN BJ, HEIMPEL H, ABKOWITZ JL. Parvovirus B19 as a cause of acquired chronic pure red cell aplasia. Br J Haematol 1994: 87: 818.
9. NEILD G, ANDERSON M, HAWES S, COLVIN BT. Parvovirus infection after renal transplant. Lancet 1986: 2: 1226.
10. PILLAY D, PATOU G, GRIFFITHS PD, REES L. Secondary parvovirus B19 infection in an immunocompromised child. Pediatr Infect Dis J 1991: 10: 623.
11. KRAUSF JR, PENCHANSKY L, KNISELY AS. Morphological diagnosis of parvovirus infection. Arch Pathol Lab Med 1992: 116: 178.
12. CORRAL DA, DARRAS FS, JENSEN CWB et al. Parvovirus B19 infection causing pure red cell aplasia in a recipient of pcdiatric donor kidneys. Transplantation 1993: 55: 427.
13. NOUR B, GREFN M, MICHAELS M et al. Parvovirus B19 infection in pediatric transplant patients. Transplantation 1993: 56: 835.
14. AL-KHALDI N, WATSON AR, HARRIS A, IRVING WL. Dual infection with human herpesvirus type 6 and parvovirus B19 in a renal transplant recipient. Pediatr Nephrol 1994: 8: 349.
15. JANNER D, BORK J, BAUM M, CHINNOCK R. Severe pneumonia after heart transplantation as a result of human parvovirus B19. J Heart Lung Transplant 1994: 13: 336.
16. RAMAGE JK, HALE A, GANE E et al. Parvovirus B19-induced red cell aplasia treated with plasmapheresis and immunoglobulin. Lancet 1994: 343: 667.
17. BERTONI E, ROSATI A, ZANAZZI M, AZZI A, ZAKREWFSKA K, GUIDI S, SALVADORI M. Severe aplastic anaemia due to B19 parvovirus infection in renal transplant recipient. Nephrol Dial Transplant 1995: 10: 1462.
18. CANTU TG, HOEHN-SARIC EW, BURGESS KM, RACUSEN L, SCHEEE PJ. Acute renal failure associated with immunoglobulin therapy. Am J Kidney Dis 1995: 2: 228.
19. UEMURA N, OZAWA K, TANI K et al. Pure red cell aplasia caused by parvovirus B19 infection in a renal transplant recipient. Eur J Haematol 1995: 54: 68.
20. BERGEN GA, SAKALOSKY PE, SINNOTT JT. Transient aplastic anemia caused by parvovirus B19 infection in a heart transplant recipient. J Heart Lung Transplant 1996: 15: 843.
21. CHANG FY, SINGH N, GAYOWSKI T, MARINO IR. Parvovirus B19 infection in a liver transplant recipient: case report and review in organ transplant recipients. Clin Transplant 1996: 10: 243.
22. STURM I, WATSCHINGER B, GEISSEER K et al. Chronic parvovirus B19 infection-associated pure red cell anaemia in a kidney transplant recipient. Nephrol Dial Transplant 1996: 11: 1367.
23. AHSAN N, HOLMAN MJ, GOCKE CD, GROFF JA, YANG HC. Pure red cell aplasia due to parvovirus B19 infection in solid organ transplantation. Clin Transplant 1997: 11: 265.
24. WEILAND HT, SALIMANS MMM, FIBBE WE, KLUIN PM, COHEN BJ. Prolonged parvovirus B19 infection with severe anaemia in a bone marrow transplant recipient. Br J Haematol 1989: 71: 300.
25. FRICKHOFEN N, ARNOLD R, HERTENSTEIN B, WIESNETH M, YOUNG NS. Parvovirus B19 infection and bone marrow transplantation. Ann Hematol 1992: 64: 121.
26. AZZI A, FANCI R, CIAPPI S, ZAKRZEWSKA K, BOSI A. Human parvovirus B19 infection in bone marrow transplantation patients. Am J Hematol 1993: 44: 207.
27. VAN HORN DK, MORTIMER PP, YOUNG N, HANSON GR. Human parvovirus-associated red cell aplasia. Am J Ped Hematol Oncol 1986: 8: 235.
28. KURTZMAN GJ, COHEN B, MEYERS P, AMUNULLAH A, YOUNG NS. Persistent B19 parvovirus infection as a cause of severe chronic anaemia in children with acute lymphocytic leukemia. Lancet 1988: 2: 1159.
29. COULOMBEL L, MORINET F, MlELOT F, TCHERNIA G. Parvovirus infection, leukemia, and immunodeficiency. Lancet 1989: 1: 101.
30. RAO SP, MILLER ST, COHEN BJ. Severe anemia due to B19 parvovirus infection in children with acute leukemia in remission. Am J Pediatr Hematol Oncol 1990: 12: 194.
31. ALLEN GRAEVE JL, DE ALARCAN PA, NAIDES SJ. Parvovirus infection in patients receiving cancer with chemotherapy: the expanding spectrum of disease. Am J Pediatr Hematol Oncol 1989: 11: 441.
32. FRICKHOFEN N, ABKOWITZ JL, SAFFORD M. BERRY M. ANTUNEZ-DE-MAYOLO JA, ASTROW A, COHEN R. Persistent B19 parvovirus infection in patients infected with Human Immunodeficiency Virus Type 1 (HIV-1): a treatable cause of anemia in AIDS. Ann Int Med 1990: 113: 926.
33. GRIFFIN TC, SQUIRES JE, TIMMONS CF, BUCHANAN GR. Chronic human parvovirus B19-induced erythroid hypoplasia as the initial manifestation of human immunodeficiency virus infection. J Pediatr 1991: 6: 899.
34. CHERNAK E, DUBIN G, HENRY D, NAIDES SJ, HODINKA RL, MACGREGOR RR, FRIEDMAN HM. Infection due to parvovirus B19 in patients infected with Human Immunodeficiency Virus. Clin Infect Dis 1995: 20: 170.
35. ANDERSON MJ, HIGGINS PG, DAVIS LR, WILLMAN JS, JONES SE, KIDD IM, PATTISON JR, TYRRELL DAJ. Experimental parvoviral infection in humans. J Infect Dis 1985: 152: 257.
36. LEFRERE JJ, COUROUCE AM, MULLER JY, CLARK M, SOULIER JP. Human parvovirus and purpura. Lancet 1985: 2: 730.
37. BERTRAND Y, LEFRERE JJ, LEVERGER G, COUROUCE AM, FEO C, CLARK M, SCHAISON G, SOULIER JP. Autoimmune haemolytic anaemia revealed by human parvovirus linked erythroblastyopenia. Lancet 1985: 2: 382.
38. SAUNDERS PWG, REID MM, COHEN BJ. Human parvovirus induced cytopenias: a report of live cases. Br J Haematol 1986: 63: 407.
39. VASSIAS I, PEROL S, COULOMBEL L et al. An in situ hybridization technique for the study of B19 human parvovirus replication in bone marrow cel cultures. J Virol Methods 1993: 44: 329.
40. TCHERNIA G, MORINET F, CONGARD B et al. Diamond Blackfan anaemia: apparent relapse due to B19 parvovirus. Eur J Pediatr 1993: 152: 209.
41. VERHEUGT FWA, VON DEM BORNE AEGKR, VAN NOORD-BOKHORST JC et al. Autoimmune granulocytopenia: the detection of granulocyte autoantibodies with the immunofluorescence test. Br J Haematol 1978: 39: 339.
42. MCCULLOUGH J, PRESS C. CLAY M. ET AL. Methods for detection of granulocyle antibodies. In: Granulocyte Serology. A clinical and Laboratory Guide, vol. 5. ASCP Press, Chicago 1988: 31.
43. SAARINEN UA, CHORBA TL, TATTERSALL P et al. Human parvovirus B19 induced epidemic red cell aplasia in patients with hereditary hemolytic anemia. Blood 1986: 67: 1411.
44. MORTIMER PP, HUMPHRIES RK, MOORE JG et al. A human parvovirus-like virus inhibits haematopoietic colony formation "in vitro". Nature 1983: 302: 426.
45. BROWN KE, ANDERSON SM, YOUNG NS. Erythrocyte P antigen: cellular receptor for B19 parvovirus. Science 1993: 262: 114.
46. SRIVASTAVA A, BRUNO E, BRIDDELL R et al. Parvovirus B19-induced perturbation of human megakaryocytopoiesis in vitro. Blood 1990: 10: 1197.
47. SOLONINKA CA, ANDERSON MJ, LASKIN CA. Anti-DNA and anti-lymphocyte antibodies during acute infection with human parvovirus B19. J Rheumatol 1989: 16: 777.
48. SASAKI T, TAKAHASHI Y, YOSHINAGA K et al. An association between human parvovirus B19 infection and autoantibody production (letter). J Rheumatol 1989: 16: 708.
49. KURTZMAN GJ, GASCON P, CARAS M et al. B19 parvovirus replicates in circulating cells of acutely infected patients. Blood 1988: 71: 1448.
50. DEBURE A, CELTON JL, CARTRON J, ROUZIOUX C, CHKOFF N, BERCHE P, KREIS H. Granulocyte-associated immunoglobulins in renal transplant recipients with cytomegalovirus infection. Lancet 1988: 2: 1338.
51. CARTRON J, BADER-MEUNIER B, DEPLANCHE M, MORINET F, VILMER E, FREYCON F, TCHERNIA G. Human parvovirus B19-associated childhood autoimmune neutropenia. Int J Pediatr Hematol Oncol 1995: 2: 471.
52. GAUTIER E, BOURHIS JH, BAYLE C, CARTRON J, PICO JL, TCHERNIA G. Parvovirus B19 associated neutropenia. Treatment with Rh G-CSF. Hematol Cell Ther 1997: 39: 85.
53. KOCH WC, MASSEY G, RUSSEL CE, ADLER SP. Manifestations and treatment of human parvovirus B19 infection in immunocompromised patients. J Pediatr 1990: 116: 355.
54. ANDERSON LJ. Role of parvovirus B19 in human disease. Pediatr Infect Dis J 1987: 6: 711.
55. TOROK TJ. Parvovirus B19 and human disease. Adv Intern Med 1992: 37: 431.
56. BARTOLOMEI CORSI O, ASSI A et al. Human parvovirus infection in haemophiliacs first infused with treated clotting factor concentrates. J Med Virol 1988: 1: 1085.
57. LYON DJ, CHAPMAN CS, MARTIN C et al. Symptomatic parvovirus B19 infection and heat-treated factor IX concentrate. Lancet 1989: 1: 1085.
58. KURTZMAN G, FRICKHOFEN NF, KIMBALL J, JENKINS DW, NIENHUIS AW, YOUNG NS. Pure red cell aplasia of 10 years' duration due to persistent parvovirus B19 infection and its cure with immunoglobulin therapy. New Engl J Med 1989: 321: 519.
59. HARTWIG NG, VERMEIJ-KEERS C, VAN ELSACKERNIELE AMW, FLEURE GJ. Embryonic malformations in a case of intrauterine parvovirus B19 infection. Teratology 1989: 39: 395.
60. CARTTER ML, FARLEY TA, ROSENGREN S et al. Occupational risk factors for infection with parvovirus B19 among pregnant women. J Infect Dis 1991: 163: 282.
61. GILLESPIE SM, CARTERR ML, ASCH S, ROKOS JB et al. Occupational risk of human parvovirus B19 infection for school and day-care personnel during an outbreak of erythema infectiosum. J Am Med Assoc 1990: 263: 2061.
62. BERTONI E, ROSATI A, ZANAZZI M, AZZI A, ZAKREWSKA K, GUIDI S, SALVADORI M. Unusual incidence of aplastic anaemia due to parvovirus infection in renal transplant recipients. Transplant Proc 1997: 29: 818.
63. AMERICAN ACADEMY OF PEDIATRICS COMMITTEE ON INFECTIOUS DISEASES. Parvovirus, erythema infectiosum, and pregnancy. Pediatrics 1990: 85: 131.